| Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: "e-PrEP" (NCT05528653) | Vivent Health | 2022-07-19 |
| A Study Evaluating An Integrated Pharmacy Digital Diary and Delivery Strategy to Increase PrEP Use Among MSM and TGW (NCT05474313) | Public Health Foundation Enterprises, Inc. | 2022-04-08 |
| Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program (NCT05856942) | University of Washington | 2022-03-08 |
| TAKE Steps: Motivational Interviewing to Prevent STIs (NCT05215262) | Children's Hospital of Philadelphia | 2022-03-08 |
| Peer PrEP Referral + HIV Self-test Delivery for PrEP Initiation in Kenya (NCT04982250) | Fred Hutchinson Cancer Center | 2022-02-24 |
| Podcasting HIV Prevention Within African American Communities (NCT05365958) | University of Houston | 2022-02-11 |
| PrEP Affect Regulation Treatment Innovation (NCT04899024) | Florida International University | 2022-01-31 |
| Randomized Controlled Trial of Game Changers (NCT05098015) | RAND | 2022-01-24 |
| Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW (NCT05018611) | University of California, Los Angeles | 2022-01-22 |
| Stick2PrEP Cisgender Women and Trans Individuals (NCT05165745) | Columbia University | 2021-10-25 |
| Integrated PrEP Interventions for People Who Inject Drugs in Rural Kentucky (NCT05037513) | Hilary L Surratt, PhD | 2021-09-16 |
| Evaluating Distribution of a Tenofovir Douche With Tap Water Douching and Simulated Receptive Anal Intercourse (NCT04195776) | Johns Hopkins University | 2021-06-01 |
| HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots (NCT04979728) | University of Colorado, Denver | 2021-05-27 |
| The Shauriana Intervention for GBMSM in Kenya (NCT04550221) | University of Washington | 2021-05-10 |
| Tenofovir Rectal Douche to Prevent HIV Transmission Among Adolescents (ATN DREAM) (NCT04686279) | University of Pennsylvania | 2021-04-01 |
| Pre-Exposure Prophylaxis for Transgender Women in the US and South America (NCT04742491) | HIV Prevention Trials Network | 2021-03-26 |
| Reducing Intersectional Stigma Among High-Risk Women in Brazil to Promote Uptake of HIV Testing and PrEP (NCT04114955) | University of California, San Francisco | 2020-12-01 |
| Pharmacy Delivery to Expand the Reach of PrEP in Kenya (NCT04558554) | University of Washington | 2020-11-26 |
| Long-acting Biomedical HIV Prevention in Transgender Women (NCT03856580) | University of Colorado, Denver | 2020-10-23 |
| Feminizing Hormone Therapy and the Rectal Mucosa Immune Environment in Transgender Women (NCT04531943) | Emory University | 2020-10-01 |
| Streamlining the Efficiency of PrEP Implementation (NCT04424524) | University of Washington | 2020-05-01 |
| Isisekelo Sempilo Trial to Optimize Peer (Thetha Nami) Delivery of HIV Prevention to Young People in Rural KwaZulu-Natal (NCT04532307) | Africa Health Research Institute | 2020-03-12 |
| Couple User Preferences in Dual Purpose Prevention Products (NCT04023799) | Microbicide Trials Network | 2020-01-21 |
| Tenofovir Rectal Douche to Prevent HIV Transmission (NCT04016233) | Johns Hopkins University | 2020-01-10 |
| Integrated HIV Prevention and HCV Care for PWID (NCT03981445) | Columbia University | 2019-11-14 |
| Griffithsin-based Rectal Microbicide for PREvention of Viral ENTry (PREVENT) (NCT04032717) | Rhonda Brand | 2019-07-10 |
| Optimizing PrEP Utilization Among Alcohol and Other Drug (AOD) Using Women of Color (NCT04018651) | Florida International University | 2019-05-31 |
| The PrEPARE Project: Prevention, Empowering, and Protecting Young Women in South Africa (NCT04048551) | RTI International | 2019-04-04 |
| A Functional Performance Study of The Wondaleaf Female Condom (NCT04076774) | Prof Mags Beksinska | 2019-03-27 |
| DOT Diary Mobile App for Pre-Exposure Prophylaxis Adherence in Young Men (NCT03771638) | Public Health Foundation Enterprises, Inc. | 2019-02-01 |
| The BeT Study Intervention to Reduce Disparities in HIV Prevention and Care (NCT05299645) | Evandro Chagas National Institute of Infectious Disease | 2019-02-01 |
| Biktarvy for Non-Occupational Post-Exposure Prophylaxis (nPEP) (NCT03499483) | Fenway Community Health | 2019-01-24 |
| Using Smart Phone Technology to Support PrEP Uptake and Adherence (NCT04868383) | University of Virginia | 2019-01-01 |
| Dat'Aids Prevention (NCT03795376) | DatAids | 2019-01-01 |
| Scalable Interventions to Increase PrEP Adherence: Value Affirmation and Future Selves (NCT03278990) | Stuart Fisk | 2018-12-19 |
| Acceptability and Performance of HIV Self-Testing in a Youth Population in Nigeria (NCT03874663) | Washington University School of Medicine | 2018-11-20 |
| An Accessible Digital Intervention to Promote HIV Testing/Counseling and Prevention Among Adolescents (NCT03713034) | Yale University | 2018-11-01 |
| The Community PrEP Study to Assess the Acceptance of PrEP Delivered Through CBCT Platforms (NCT03977181) | Foundation for Professional Development (Pty) Ltd | 2018-10-26 |
| Single Dose Truvada Study (NCT03719053) | Johns Hopkins University | 2018-10-25 |
| PrEP-Pod-IVR (TDF-FTC/Placebo IVR 28 Day Crossover Study) (NCT03255915) | Oak Crest Institute of Science | 2018-09-20 |
| HIV Self-testing in Implementation PrEP Study (NCT03642314) | Oswaldo Cruz Foundation | 2018-09-01 |
| Microbicide/PrEP Acceptability Among Mothers and Male Partners in Africa (NCT03648931) | Microbicide Trials Network | 2018-05-31 |
| ATN 151 Work-to-Prevent: Employment as HIV Prevention (NCT03313310) | University of North Carolina, Chapel Hill | 2018-03-20 |
| Youth-focused Strategies to Promote Adherence to Pre-exposure Prophylaxis Among Youth At-risk for HIV in Thailand (NCT03778892) | Chulalongkorn University | 2018-03-01 |
| Integrated BA and HIV RR Counseling for MSM With Stimulant Abuse (NCT03175159) | University of California, Los Angeles | 2018-03-01 |
| DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence (NCT03387462) | Public Health Foundation Enterprises, Inc. | 2018-02-28 |
| A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender Women (NCT03270969) | University of Nebraska | 2018-01-05 |
| Periconception PrEP for HIV-exposed Ugandan Women (NCT03832530) | Massachusetts General Hospital | 2017-11-27 |
| Western Australian Pre-exposure Prophylaxis for HIV Implementation Trial (NCT03327155) | Kirby Institute | 2017-11-16 |
| Safer Conception for Women - Understanding Use of Periconception PrEP (NCT03194308) | Massachusetts General Hospital | 2017-11-13 |
| ImQuest (IQP) DuoGel Phase 1 Pharmacokinetic Study (NCT03082690) | Johns Hopkins University | 2017-11-01 |
| Project WERK (Wellness Encouragement Respect Kinship) (NCT03148171) | University of Chicago | 2017-10-09 |
| Preventing HIV Among Native Americans Through the Treatment PTSD & Substance Use (NCT03112369) | University of Washington | 2017-09-21 |
| Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy (NCT04050371) | University of California, San Francisco | 2017-08-03 |
| Implementation of PrEP to HIV in Brazilian Transgender Women (NCT03220152) | Oswaldo Cruz Foundation | 2017-07-10 |
| Social Media Based Peer-Led Intervention for HIV Prevention (NCT03213366) | Montefiore Medical Center | 2017-06-16 |
| PK and Safety Study of Vaginal Rings Containing Dapivirine and Levonorgestrel (NCT02855346) | International Partnership for Microbicides, Inc. | 2017-05-03 |
| Safety and Acceptability Study of PrePex Device When Removing the Foreskin Shortly After Placement of Device (NCT03132285) | Ministry of Health, Zambia | 2017-03-11 |
| VRC 605: Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered Intravenously or Subcutaneously to Healthy Adults (NCT03015181) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-02-21 |
| Demonstration Project on the Feasibility to Implement PrEP in MSM and TG Women (NCT03043326) | Asociación Civil Impacta Salud y Educación, Peru | 2017-01-23 |
| HOME Study: a Combination Support Package to Increase Uptake of PrEP and HIV/STI Testing (NCT03138135) | Public Health Foundation Enterprises, Inc. | 2017-01-09 |
| Digital Health Feedback System (DHFS) for Longitudinal Monitoring of ARVs Used in HIV Pre-exposure Prophylaxis (PrEP) (NCT03693040) | University of California, San Diego | 2016-12-01 |
| Optimization of a Tenofovir Enema for HIV Prevention (NCT02750540) | Johns Hopkins University | 2016-10-01 |
| To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negative Women (NCT02862171) | International Partnership for Microbicides, Inc. | 2016-07-12 |
| Assessment of ASPIRE and HOPE Adherence (NCT02702895) | Microbicide Trials Network | 2016-06-13 |
| STI Care Model to Reduce Genital Inflammation and HIV Risk in South African Women (NCT03407586) | Centre for the AIDS Programme of Research in South Africa | 2016-05-15 |
| Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women (NCT02584140) | University of California, Los Angeles | 2016-05-01 |
| Finding the Right Tenofovir/Emtricitabine Regimen for Pre-Exposure Prophylaxis (PrEP) in Transgender Women (NCT03060785) | Johns Hopkins University | 2016-03-08 |
| Helping Men Have Healthy Babies (NCT03818984) | Massachusetts General Hospital | 2015-11-06 |
| To Assess the Drug-drug Interaction Potential Between Dapivirine Vaginal Ring-004, Containing 25 mg of Dapivirine, and Clotrimazole 10 mg/g (1%) (NCT02847286) | International Partnership for Microbicides, Inc. | 2015-09-01 |
| Evaluation of PrEP-30: a Demonstration Project of Pre-exposure Prophylaxis for MSM and Other High-risk Group Clients at the Thai Red Cross Anonymous Clinic (NCT02437981) | Thai Red Cross AIDS Research Centre | 2014-12-01 |
| Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel (NCT01768962) | CONRAD | 2014-04-01 |
| In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products (NCT01813162) | CONRAD | 2013-12-01 |
| Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity (NCT01810315) | CONRAD | 2013-09-01 |
| SEPA III: The Effectiveness Trial (NCT02405481) | University of Miami | 2013-06-01 |
| A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services (NCT01781806) | University of California, Los Angeles | 2013-05-01 |
| Biomarkers of Protocol Compliance and Product Adherence (NCT01804023) | CONRAD | 2013-03-01 |
| An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations (NCT01575418) | Ian McGowan | 2013-03-01 |
| A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally (NCT01575405) | Ian McGowan | 2013-03-01 |
| Formative Research for an HIV Videogame for Young Black Women (NCT02685410) | Yale University | 2013-01-01 |
| An Exploratory Study of Potential Sources of Efficacy Dilution in the VOICE Trial (MTN-003) (NCT02358616) | Microbicide Trials Network | 2012-12-01 |
| An Integrated HIV Prevention Model for African American Mothers and Daughters (NCT02958813) | University of Illinois at Chicago | 2012-11-01 |
| Follow Up Study to Evaluate a Non-Surgical Device for Adult Male Circumcision for Screen Failure Subjects (NCT02281435) | Ministry of Health, Rwanda | 2012-11-01 |
| Couples in Context: An RCT of a Couples-based HIV Prevention Intervention (NCT01953133) | University of California, San Francisco | 2012-04-01 |
| Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use (NCT01421368) | CONRAD | 2012-03-01 |
| Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection (NCT01386294) | CONRAD | 2011-10-01 |
| Integrated Mental Health Treatment & HIV Prevention for Court-Involved Youth (NCT01421485) | Rhode Island Hospital | 2011-08-01 |
| Four-Arm Randomized Control Trial of Brief MI Versus Couples-Based HIV/STI Prevention in South Africa (NCT01554423) | The City College of New York | 2010-07-01 |
| Raltegravir Use as Nonoccupational Postexposure Prophylaxis (NPEP) in Men Who Have Sex With Men (NCT01087840) | Andrew Carr | 2010-07-01 |
| A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodology for Rapid Scale up of Painless and Bloodless National Circumcision Programs, in Urban and Remote Rural Settings (NCT01150370) | Ministry of Health, Rwanda | 2010-06-01 |
| Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV (NCT00949234) | University of California, Los Angeles | 2010-03-01 |
| The Shang Ring: A Novel Male Circumcision Device for HIV Prevention (NCT00993811) | Weill Medical College of Cornell University | 2009-10-01 |
| Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet (NCT00984971) | CONRAD | 2009-09-01 |
| Development and Testing of a Jamaican Mother-daughter HIV Risk-reduction Program (NCT03411577) | Boston College | 2007-09-29 |
| HIV- Risk Reduction Behavioral Intervention for Commercial Sex Workers in Yerevan Armenia (NCT00886561) | Emory University | 2007-07-01 |
| Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility - 1 (NCT00142935) | The Miriam Hospital | 2006-09-01 |
| Adopting and Demonstrating the Adaptation of Prevention Techniques: Community PROMISE PLUS (NCT00267436) | Centers for Disease Control and Prevention | 2006-07-01 |
| S.T.A.R.S.: Sistas Talking About Real Solutions (NCT01028157) | Emory University | 2002-10-01 |
| Paper Applicator Acceptability Study (NCT02179138) | CONRAD | |
| Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females (NCT02245945) | CONRAD | |